Literature DB >> 11591962

Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis.

K Shetler1, R Nieuwenhuis, S M Wren, G Triadafilopoulos.   

Abstract

BACKGROUND: We explored the potential of early decompressive colonoscopy with intracolonic vancomycin administration as an adjunctive therapy for severe pseudomembranous Clostridium difficile colitis with ileus and toxic megacolon.
METHODS: We reviewed the symptoms, signs, laboratory tests, radiographic findings, and outcomes from the medical records of seven patients who experienced eight episodes of severe pseudomembranous colitis with ileus and toxic megacolon. All seven patients underwent decompressive colonoscopy with intracolonic perfusion of vancomycin.
RESULTS: Fever, abdominal pain, diarrhea, abdominal distention, and tenderness were present in all patients. Five of seven patients were comatose, obtunded, or confused, and six of the seven required ventilatory support. The white blood cell count was greater than 16,000 in seven cases (six patients). Colonoscopy showed left-side pseudomembranous colitis in one patient, right-side colitis in one patient, and diffuse pseudomembranous pancolitis in five patients. Two patients were discharged with improvement. Five patients had numerous medical problems leading to their death. Complete resolution of pseudomembranous colitis occurred in four patients. One patient had a partial response, and two patients failed therapy.
CONCLUSION: Colonoscopic decompression and intracolonic vancomycin administration in the management of severe, acute, pseudomembranous colitis associated with ileus and toxic megacolon is feasible, safe, and effective in approximately 57% to 71% of cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591962     DOI: 10.1007/s004640080104

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

Review 1.  [Toxic megacolon].

Authors:  M Leppkes; M Ganslmayer; R Strauß; M F Neurath
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-14       Impact factor: 0.840

2.  Management of severe Clostridium difficile-associated diarrhea.

Authors:  Michael J Krier; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2009-02-19       Impact factor: 3.199

3.  [Challenges of Clostridium difficile infection].

Authors:  A Ebigbo; H Messmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-10-17       Impact factor: 0.840

Review 4.  Treatment of recurrent Clostridium difficile infection: a systematic review.

Authors:  J C O'Horo; K Jindai; B Kunzer; N Safdar
Journal:  Infection       Date:  2013-07-10       Impact factor: 3.553

5.  Pseudomembranous colitis presenting as acute colonic obstruction without diarrhea in a patient with gastric Burkitt lymphoma.

Authors:  Kenichi Nomura; Kohei Fukumoto; Daisuke Shimizu; Takashi Okuda; Naohisa Yoshida; Yuri Kamitsuji; Yosuke Matsumoto; Hideyuki Konishi; Yuji Ueda; Shigeo Horiike; Takeshi Okanoue; Masafumi Taniwaki
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

6.  Toxic megacolon associated Clostridium difficile colitis.

Authors:  Leena Sayedy; Darshan Kothari; Robert J Richards
Journal:  World J Gastrointest Endosc       Date:  2010-08-16

7.  Current Treatment Options for Severe Clostridium difficile-associated Disease.

Authors:  Edie P Shen; Christina M Surawicz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-02

8.  Intracolonic vancomycin for severe Clostridium difficile colitis.

Authors:  Peter K Kim; Heesun C Huh; Hillel W Cohen; Elyssa J Feinberg; Salman Ahmad; Christina Coyle; Sheldon Teperman; Hugh Boothe
Journal:  Surg Infect (Larchmt)       Date:  2013-04-05       Impact factor: 2.150

9.  Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis.

Authors:  Eran Elinav; David Planer; Moshe E Gatt
Journal:  Int J Colorectal Dis       Date:  2003-11-15       Impact factor: 2.571

10.  Vancomycin Enemas as Adjunctive Therapy for Clostridium difficile Infection.

Authors:  Mark Malamood; Eric Nellis; Adam C Ehrlich; Frank K Friedenberg
Journal:  J Clin Med Res       Date:  2015-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.